[1]
“A Prospective Observational Study of Anthropometric Parameters in Patients with Type 2 Diabetes Mellitus Receiving Dipeptidyl Peptidase-4 Inhibitors: Research Article”, JOPIR, vol. 3, no. 6, pp. 225–230, Dec. 2025, doi: 10.69613/wq9ask44.